• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD have to make a difficult choice about whether to continue or stop taking ADHD medication during pregnancy and breastfeeding. There aren't enough data regarding how exposure over time may affect a foetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus do not develop neurological disorders like hearing or vision impairment seizures, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality research.

Risk/Benefit Analysis

Pregnant women who take ADHD medications must weigh the advantages of taking them against potential risks to the foetus. The doctors don't have the information to provide clear recommendations, but can provide information on the risks and benefits to assist pregnant women to make an informed decision.

A study published in Molecular Psychiatry concluded that women who took ADHD medication in early pregnancy were not at a higher risk of fetal malformations or structural birth defects. Researchers conducted a large, population-based case-control study to determine the prevalence of major structural birth defects in infants born to mothers who had taken stimulants in the early stages of pregnancy, and those who did not. Clinical geneticists and pediatric cardiologists examined the cases to ensure an accurate case classification and to limit the possibility of bias.

The study conducted by the researchers was not without its limitations. The most important issue was that they were not able to differentiate the effects of the medication from the effects of the disorder that is underlying. This limitation makes it difficult to know whether the limited associations observed in the groups that were exposed are due to the use of medication or confounding by comorbidities. Additionally, the researchers did not look at the long-term outcomes of offspring.

The study revealed that babies whose mothers had taken liquid adhd medication uk (read this blog article from linenchain00.bravejournal.net) medication during pregnancy had a greater risk of being admitted to the neonatal care unit (NICU) in comparison to those whose mothers did not take any medication during pregnancy or had quit taking the medication prior to or during pregnancy. The reason for this was central nervous system-related disorders, and the increased risk of admission did not appear to be influenced by which stimulant medications were used during pregnancy.

Women who took stimulant ADHD medication during pregnancy were also at an increased risk of having a caesarean delivery or having a baby with low Apgar score (less than 7). These increases did not appear to be influenced by the kind of medication used during pregnancy.

Researchers suggest that the small risks posed by the use of ADHD medications during early pregnancies may be offset by the greater benefits to both baby and mother of continued treatment for the woman’s disorder. Doctors should discuss with their patients about this issue and as much as possible, assist them develop coping skills that can lessen the effects of her disorder on her daily functioning and her relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and being treated with medication, the dilemma of whether to continue or discontinue treatment during pregnancy is one that doctors are having to confront. These decisions are often made without clear and reliable evidence. Instead, doctors must take into account their own experience in conjunction with the experiences of other doctors and the research that has been conducted on the subject.

The issue of potential risks to the infant can be extremely difficult. The research on this issue is based on observations rather than controlled studies, and the results are conflicting. Furthermore, most studies restrict their analysis to live births, which may undervalue the serious teratogenic effects that can result in abortion or termination of the pregnancy. The study presented in this journal club addresses these limitations by analyzing data on live and deceased births.

Conclusion: While some studies have found a positive correlation between ADHD medications and certain birth defects, other studies have not shown such a relationship. Most studies have shown a neutral, or even somewhat negative, impact. In each case an in-depth evaluation of the risks and benefits is required.

For a lot of women with ADHD who suffer from ADHD, the decision to stop medication can be difficult, if not impossible. In an article published in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping adhd medication list medication during pregnancy can lead to increased depression, feelings of isolation and family conflict for those suffering from the disorder. A decrease in medication could also affect the ability to drive safely and perform work-related tasks, which are vital aspects of everyday life for those with ADHD.

She suggests that women who are not sure whether to take the medication or stop it due to their pregnancy, educate their family members, coworkers and their friends about the condition, the impact on daily functioning and the advantages of staying on the current treatment plan. In addition, educating them can help the woman feel supported as she struggles with her decision. Some medications can pass through the placenta. If a patient decides not to take her ADHD medication while breastfeeding, it's important to be aware that the drug could be passed on to her infant.

Birth Defects Risk

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) increases there are concerns about the effects that the drugs might have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this subject. Researchers used two massive data sets to study over 4.3 million pregnant women and determine whether stimulant medications increased the risk of birth defects. Although the risk overall remains low, the researchers discovered that the first-trimester exposure to ADHD medicines was associated with an increased risk of certain heart defects such as ventriculoseptal defect (VSD).

The authors of the study didn't discover any connection between early use of medication and other congenital anomalies, such as facial deformities or club feet. The results are in the same vein as previous studies which showed a small, but significant increase in cardiac malformations for women who started taking ADHD medication before the time of pregnancy. The risk increased in the latter stages of pregnancy, when a lot of women stopped taking their medication.

Women who took ADHD medication during the first trimester were more likely need a caesarean and also have a low Apgar after birth and had a baby that required breathing assistance when they were born. However the researchers of the study were not able to eliminate bias due to selection by limiting the study to women who did not have any other medical conditions that could be a contributing factor to these findings.

The researchers hope that their research will help inform the clinical decisions of doctors who treat pregnant women. The researchers recommend that, while discussing the risks and benefits are important, the decision about whether to continue or stop medication should be made according to the severity of each woman's ADHD symptoms and her requirements.

The authors also advise that even though stopping the medication is an option, it is not an option that is recommended due to the high prevalence of depression and other mental health problems in women who are pregnant or who are recently postpartum. Additionally, research suggests that women who stop taking their medications will have a difficult time adjusting to a life without them once the baby is born.

Nursing

It can be a stressful experience to become a mom. Women who suffer from common adhd medications uk can face severe challenges when they have to manage their symptoms, attend doctor appointments, prepare for the birth of a child and adjust to a new routine. Therefore, many women decide to continue taking their ADHD medications throughout the course of pregnancy.

The majority of stimulant medications pass through breast milk in very small amounts, so the risk to the nursing infant is very low. However, the rate of exposure to medications by the newborn may differ based on the dosage, frequency it is administered and the time of day it is administered. In addition, individual medications enter the infant's system differently through the gastrointestinal tract and breast milk and the impact of this on a newborn is not fully known.

Some doctors may stop taking stimulant medication during a woman's pregnancy due to the lack of research. This is a difficult choice for the patient, who must weigh the benefits of keeping her medication against the potential dangers to the embryo. Until more information is available, doctors should ask all pregnant patients about their history of ADHD and whether they are taking or planning to take medication during the perinatal time.

A increasing number of studies have revealed that the majority of women are able to safely continue to take their ADHD medication while they are pregnant and nursing. As a result, an increasing number of patients choose to do so and, in consultation with their physician, they have discovered that the benefits of keeping their current medication far outweigh any potential risks.

Women who suffer from ADHD who are planning to breastfeed should seek the advice of a specialist psychiatrist before becoming pregnant. They should discuss their medication with their physician and discuss the pros and cons of continued treatment, including non prescription adhd medication-pharmacological management strategies. Psychoeducation is also needed to help pregnant women suffering from ADHD be aware of the symptoms and underlying disorder. They should also be informed about treatment options and strengthen coping mechanisms. This should be a multidisciplinary approach including obstetricians, GPs and psychiatry. Pregnancy counselling should include the discussion of a plan for management for both the mother and child, as well as monitoring for signs of deterioration, and the need for adjustments to the medication regimen.